Skip to main content
. 2021 Sep 2;11:702258. doi: 10.3389/fonc.2021.702258

Figure 3.

Figure 3

Expression analysis of miR-122-5p and miR-142-5p in EVs. (A, B) Expression levels of miR-122-5p and miR-142-5p were significantly lower in plasma EVs of RC patients compared to EVs of cancer-free individuals (for all p <0.001). (C, D) A year from the diagnosis (2nd sampling, T1), a significant difference was observed between patients that do not respond a year after diagnosis and cancer-free individuals for miR-122-5p (4.9-fold change, p=0.007). This trend was not observed for miR-142-5p. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001.